» Articles » PMID: 26697887

Defective PITRM1 Mitochondrial Peptidase is Associated with Aβ Amyloidotic Neurodegeneration

Abstract

Mitochondrial dysfunction and altered proteostasis are central features of neurodegenerative diseases. The pitrilysin metallopeptidase 1 (PITRM1) is a mitochondrial matrix enzyme, which digests oligopeptides, including the mitochondrial targeting sequences that are cleaved from proteins imported across the inner mitochondrial membrane and the mitochondrial fraction of amyloid beta (Aβ). We identified two siblings carrying a homozygous PITRM1 missense mutation (c.548G>A, p.Arg183Gln) associated with an autosomal recessive, slowly progressive syndrome characterised by mental retardation, spinocerebellar ataxia, cognitive decline and psychosis. The pathogenicity of the mutation was tested in vitro, in mutant fibroblasts and skeletal muscle, and in a yeast model. A Pitrm1(+/-) heterozygous mouse showed progressive ataxia associated with brain degenerative lesions, including accumulation of Aβ-positive amyloid deposits. Our results show that PITRM1 is responsible for significant Aβ degradation and that impairment of its activity results in Aβ accumulation, thus providing a mechanistic demonstration of the mitochondrial involvement in amyloidotic neurodegeneration.

Citing Articles

Fetal and obstetrics manifestations of mitochondrial diseases.

Adelizzi A, Giri A, Di Donfrancesco A, Boito S, Prigione A, Bottani E J Transl Med. 2024; 22(1):853.

PMID: 39313811 PMC: 11421203. DOI: 10.1186/s12967-024-05633-6.


Investigating copy number variants in schizophrenia pedigrees using a new consensus pipeline called PECAN.

Ormond C, Ryan N, Byerley W, Heron E, Corvin A Sci Rep. 2024; 14(1):17518.

PMID: 39080331 PMC: 11289470. DOI: 10.1038/s41598-024-66021-0.


Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.

Meng X, Song Q, Liu Z, Liu X, Wang Y, Liu J Front Aging Neurosci. 2024; 16:1400544.

PMID: 38808033 PMC: 11130508. DOI: 10.3389/fnagi.2024.1400544.


Profiling Protein-Protein Interactions in the Human Brain by Refined Cofractionation Mass Spectrometry.

Shrestha H, Lee D, Wu Z, Wang Z, Fu Y, Wang X J Proteome Res. 2024; 23(4):1221-1231.

PMID: 38507900 PMC: 11065482. DOI: 10.1021/acs.jproteome.3c00685.


Mitophagy in Alzheimer's Disease: A Bibliometric Analysis from 2007 to 2022.

Wang H, Yan X, Zhang Y, Wang P, Li J, Zhang X J Alzheimers Dis Rep. 2024; 8(1):101-128.

PMID: 38312534 PMC: 10836605. DOI: 10.3233/ADR-230139.


References
1.
Falkevall A, Alikhani N, Bhushan S, Pavlov P, Busch K, Johnson K . Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J Biol Chem. 2006; 281(39):29096-104. DOI: 10.1074/jbc.M602532200. View

2.
Burns J, Pennock C, STOWARD P . The specificity of the staining of amyloid deposits with thioflavine T. J Pathol Bacteriol. 1967; 94(2):337-44. DOI: 10.1002/path.1700940211. View

3.
Fleming S, Zhu C, Fernagut P, Mehta A, DiCarlo C, Seaman R . Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol. 2004; 187(2):418-29. DOI: 10.1016/j.expneurol.2004.01.023. View

4.
Mishra P, Chan D . Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol. 2014; 15(10):634-46. PMC: 4250044. DOI: 10.1038/nrm3877. View

5.
Pinho C, Teixeira P, Glaser E . Mitochondrial import and degradation of amyloid-β peptide. Biochim Biophys Acta. 2014; 1837(7):1069-74. DOI: 10.1016/j.bbabio.2014.02.007. View